Gujarat Themis Biosyn Ltd
NSE: GUJTHEM BSE: 506879
₹371.95
(4.42%)
Fri, 16 Oct 2026, 11:56 am
Market Cap (in Cr)5102.6
PE Ratio83.25
Dividend0.17
Health Technology
Pharmaceuticals: Major
24.5KGujarat Themis Biosyn Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 159.35M | 115.02M | 158.62M | 125.52M | 154.79M | 133.82M | 84.38M | 283.26M | 302.30M | 314.40M | 326.25M | 355.87M | 388.00M | 410.50M | 851.24M | 905.63M | 1.15B | 1.48B | 1.70B | 1.51B |
| Gross profit | -34.86M | -49.93M | 11.13M | -5.20M | 7.74M | -16.75M | -27.99M | 34.46M | 71.27M | 73.37M | 62.53M | 65.37M | 71.95M | 91.88M | 376.82M | 423.33M | 611.32M | 797.16M | 863.27M | 737.05M |
| Operating expenses (excl. COGS) | -15.36M | -55.30M | -10.39M | -15.18M | -5.39M | -6.05M | -6.91M | -11.14M | -20.61M | -21.21M | -13.45M | -15.79M | -18.31M | -29.38M | -70.76M | -24.72M | -39.25M | -75.26M | -110.93M | -81.64M |
| Selling/general/admin expenses, total | -15.26M | -55.72M | -12.26M | -15.03M | -5.23M | -6.05M | -7.11M | -10.71M | -10.66M | -12.19M | -12.20M | -14.22M | -15.83M | -11.83M | -18.30M | -18.27M | -25.93M | -67.60M | -89.25M | -58.54M |
| Research & development | -831.00K | — | -382.00K | — | 0 | -166.00K | — | — | 0 | 0 | 0 | — | -280.00K | -304.00K | 0 | 0 | -4.50M | -29.32M | -38.92M | -3.57M |
| Selling/general/admin expenses, other | -14.42M | -55.72M | -11.88M | -15.03M | -5.23M | -5.88M | -7.11M | -10.71M | -10.66M | -12.19M | -12.20M | -14.22M | -15.55M | -11.52M | -18.30M | -18.27M | -21.43M | -38.27M | -50.32M | -54.97M |
| Other operating expenses, total | -107.53K | 420.63K | 1.87M | -151.61K | -158.07K | 0 | 203.82K | -424.49K | -9.94M | -9.02M | -1.25M | -1.56M | -2.48M | -17.55M | -52.45M | -6.46M | -13.31M | -7.66M | -21.68M | -23.10M |
| Operating income | -50.23M | -105.23M | 740.41K | -20.38M | 2.35M | -22.80M | -35.33M | 23.33M | 50.66M | 52.17M | 49.08M | 49.59M | 53.64M | 62.51M | 306.06M | 398.61M | 572.07M | 721.90M | 752.34M | 655.41M |
| Non-operating income, total | 23.23M | -14.99M | -18.35M | -15.54M | -12.71M | -9.85M | 51.20M | -12.63M | -5.40M | -6.22M | -2.79M | -737.00K | -5.26M | 19.45M | 6.51M | 10.21M | 18.27M | 52.75M | 41.01M | -30.00K |
| Interest expense, net of interest capitalized | -11.80M | -18.06M | -16.42M | -18.53M | -16.17M | -11.49M | -9.18M | -7.47M | -6.65M | -3.87M | -3.77M | -3.84M | -2.46M | -1.30M | -3.62M | -7.17M | -8.28M | -1.76M | -2.29M | -3.64M |
| Interest capitalized | — | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 35.03M | 3.09M | -2.26M | 1.36M | 5.14M | 2.07M | 3.63M | 2.06M | 1.38M | -2.32M | 1.70M | 601.00K | -1.24M | 21.48M | 1.97M | 17.38M | 26.55M | 54.51M | 43.30M | 3.61M |
| Non-operating interest income | 6.99M | 582.54K | 675.34K | 814.30K | 510.72K | 1.14M | 729.50K | 831.88K | 772.08K | 448.36K | 985.23K | 402.00K | 1.25M | 3.63M | 7.56M | 14.83M | 32.61M | 50.44M | 40.25M | 7.04M |
| Miscellaneous non-operating expense | 28.04M | 2.51M | -2.94M | 543.09K | 4.63M | 935.58K | 2.90M | 1.23M | 610.81K | -2.76M | 715.20K | 199.00K | -2.49M | 17.85M | -5.59M | 2.55M | -6.06M | 4.06M | 3.04M | -3.43M |
| Unusual income/expense | 3.49K | -20.90K | 339.46K | 1.64M | -1.68M | -436.02K | 56.75M | -7.22M | -137.74K | -36.49K | -713.72K | 2.50M | -1.56M | -738.00K | 8.15M | 0 | 0 | 0 | 0 | 0 |
| Pretax income | -26.99M | -120.22M | -17.61M | -35.92M | -10.36M | -32.65M | 15.87M | 10.70M | 45.26M | 45.94M | 46.29M | 48.85M | 48.38M | 81.96M | 312.57M | 408.82M | 590.35M | 774.65M | 793.34M | 655.38M |
| Taxes | 0 | 0 | 0 | -435.50K | -474.04K | -115.16K | 0 | 0 | 0 | 0 | 0 | -5.07M | -9.71M | -17.87M | -75.82M | -107.02M | -154.10M | -194.96M | -201.71M | -167.66M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | -26.99M | -120.22M | -17.61M | -36.35M | -10.83M | -32.77M | 15.87M | 10.70M | 45.26M | 45.94M | 46.29M | 43.77M | 38.67M | 64.09M | 236.75M | 301.80M | 436.24M | 579.69M | 591.63M | 487.72M |
| Net income | -26.99M | -120.22M | -17.61M | -36.35M | -10.83M | -32.77M | 15.87M | 10.70M | 45.26M | 45.94M | 46.29M | 43.77M | 38.67M | 64.09M | 236.75M | 301.80M | 436.24M | 579.69M | 591.63M | 487.72M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | -26.99M | -120.22M | -17.61M | -36.35M | -10.83M | -32.77M | 15.87M | 10.70M | 45.26M | 45.94M | 46.29M | 43.77M | 38.67M | 64.09M | 236.75M | 301.80M | 436.24M | 579.69M | 591.63M | 487.72M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | -31.55M | -86.56M | 19.59M | -8.80M | 12.76M | -12.10M | -23.86M | 37.57M | 65.29M | 65.92M | 61.07M | 60.78M | 65.13M | 74.72M | 319.68M | 415.93M | 594.40M | 747.66M | 787.70M | 709.16M |
| EBIT | -50.23M | -105.23M | 740.40K | -20.38M | 2.35M | -22.80M | -34.89M | 23.33M | 50.66M | 52.17M | 49.08M | 49.59M | 53.64M | 62.51M | 306.06M | 398.61M | 572.07M | 721.90M | 752.34M | 655.41M |
| Total operating expenses | -209.58M | -220.25M | -157.88M | -145.90M | -152.44M | -156.62M | -119.71M | -259.94M | -251.64M | -262.24M | -277.17M | -306.29M | -334.36M | -347.99M | -545.19M | -507.02M | -576.47M | -761.95M | -945.88M | -852.59M |
| Prepaid expenses | 4.60M | 4.82M | 7.57M | 7.98M | 10.62M | 7.22M | 1.34M | 1.75M | 1.37M | 1.16M | 1.19M | 988.00K | 241.00K | 0 | 2.50M | 2.94M | 3.12M | 4.70M | 3.59M | 1.58M |
| Deferred income, current | — | — | — | — | — | — | — | — | 60.92M | 22.48M | 76.72K | 77.00K | 90.00K | 28.00K | 20.00K | 21.00K | 19.00K | 0 | — | 31.00K |
| Capital and operating lease obligations | 202.12K | 211.96K | 12.82K | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.01M | 4.19M | 12.25M | 12.25M | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | 23.55M | 19.52M | 17.40M | 15.98M | 14.79M | 15.36M | 13.68M | 11.73M | 11.11M | 507.00K | — | 9.17M | 8.64M | 9.79M | 10.24M | 13.00M | 16.64M | 19.62M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -23.97M | -100.01M | -124.35M | -69.01M | -18.17M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
